Further studies are required to fully comprehend the long-term clinical significance of MRI changes seen after platelet-rich plasma therapy for focal early knee osteoarthritis and how this varies ...

Cytonics Corporation, a private biotechnology company developing cutting-edge biologic therapies for musculoskeletal conditions, today announced that the first nine patients in its Phase 1 clinical ...

Contura Orthopaedics Ltd has announced announce that the pioneering, non-biodegradable hydrogel injectable implant ...

A new study in the December 2024 issue of the Journal of Vascular and Interventional Radiology shows that this type of ...

AROUND 10 million people in the UK have osteoarthritis with an estimated 350,000 new cases diagnosed each year.

New developments in regenerative medicine are providing alternative solutions that aim to address the underlying issues of ...